CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands |
Total |
Common Class A |
Common Class B |
Common Stock
Common Class A
|
Common Stock
Common Class B
|
Additional Paid-in Capital |
(Accumulated Deficit) |
Accumulated Other Comprehensive Income (Loss) |
| Beginning balance (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
4,668,678
|
|
134,839
|
|
|
|
|
| Beginning balance at Dec. 31, 2021 |
|
$ 652,205
|
|
|
$ 1,401
|
[1] |
$ 40
|
[1] |
$ 1,671,195
|
$ (1,020,142)
|
$ (289)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(11,073)
|
|
|
|
|
|
|
|
(11,073)
|
|
| Compensation expense related to granting of stock awards (in shares) |
[1] |
|
|
|
(1,978)
|
|
|
|
|
|
|
| Compensation expense related to granting of stock awards |
|
2,698
|
|
|
$ (1)
|
[1] |
|
|
2,699
|
|
|
| Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") (in shares) |
[1] |
|
|
|
2,034
|
|
|
|
|
|
|
| Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") |
|
177
|
|
|
$ 1
|
[1] |
|
|
176
|
|
|
| Purchase of vested employee restricted stock units (in shares) |
[1] |
|
|
|
(20,729)
|
|
|
|
|
|
|
| Purchase of vested employee restricted stock units |
|
(1,839)
|
|
|
$ (6)
|
[1] |
|
|
(1,833)
|
|
|
| Payment of dividends on common stock |
|
(174)
|
|
|
|
|
|
|
(174)
|
0
|
|
| Dividend equivalents, net of forfeitures |
|
202
|
|
|
|
|
|
|
|
202
|
0
|
| Net unrealized gain (loss) on derivatives |
|
1,223
|
|
|
|
|
|
|
|
0
|
1,223
|
| Ending balance (in shares) at Mar. 31, 2022 |
[1] |
|
|
|
4,648,005
|
|
134,839
|
|
|
|
|
| Ending balance at Mar. 31, 2022 |
|
643,419
|
|
|
$ 1,395
|
[1] |
$ 40
|
[1] |
1,672,063
|
(1,031,013)
|
934
|
| Beginning balance (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
4,668,678
|
|
134,839
|
|
|
|
|
| Beginning balance at Dec. 31, 2021 |
|
652,205
|
|
|
$ 1,401
|
[1] |
$ 40
|
[1] |
1,671,195
|
(1,020,142)
|
(289)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(11,846)
|
|
|
|
|
|
|
|
|
|
| Net unrealized gain (loss) on derivatives |
|
1,776
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2022 |
[1] |
|
|
|
4,709,885
|
|
134,839
|
|
|
|
|
| Ending balance at Jun. 30, 2022 |
|
645,761
|
|
|
$ 1,413
|
[1] |
$ 40
|
[1] |
1,674,603
|
(1,031,782)
|
1,487
|
| Beginning balance (in shares) at Mar. 31, 2022 |
[1] |
|
|
|
4,648,005
|
|
134,839
|
|
|
|
|
| Beginning balance at Mar. 31, 2022 |
|
643,419
|
|
|
$ 1,395
|
[1] |
$ 40
|
[1] |
1,672,063
|
(1,031,013)
|
934
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(773)
|
|
|
|
|
|
|
|
(773)
|
|
| Compensation expense related to granting of stock awards (in shares) |
[1] |
|
|
|
57,934
|
|
|
|
|
|
|
| Compensation expense related to granting of stock awards |
|
2,481
|
|
|
$ 17
|
[1] |
|
|
2,464
|
|
|
| Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") (in shares) |
[1] |
|
|
|
4,706
|
|
|
|
|
|
|
| Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") |
|
132
|
|
|
$ 1
|
[1] |
|
|
131
|
|
|
| Purchase of vested employee restricted stock units (in shares) |
[1] |
|
|
|
(760)
|
|
|
|
|
|
|
| Purchase of vested employee restricted stock units |
|
(51)
|
|
|
|
|
|
|
(51)
|
|
|
| Payment of dividends on common stock |
|
(4)
|
|
|
|
|
|
|
(4)
|
|
|
| Dividend equivalents, net of forfeitures |
|
4
|
|
|
|
|
|
|
|
4
|
|
| Net unrealized gain (loss) on derivatives |
|
553
|
|
|
|
|
|
|
|
|
553
|
| Ending balance (in shares) at Jun. 30, 2022 |
[1] |
|
|
|
4,709,885
|
|
134,839
|
|
|
|
|
| Ending balance at Jun. 30, 2022 |
|
645,761
|
|
|
$ 1,413
|
[1] |
$ 40
|
[1] |
1,674,603
|
(1,031,782)
|
1,487
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
|
4,705,328
|
134,839
|
4,705,328
|
[2] |
134,839
|
[2] |
|
|
|
| Beginning balance at Dec. 31, 2022 |
|
520,619
|
|
|
$ 1,412
|
[2] |
$ 40
|
[2] |
1,676,843
|
(1,160,618)
|
2,942
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(35,901)
|
|
|
|
|
|
|
|
(35,901)
|
|
| Compensation expense related to granting of stock awards (in shares) |
[2] |
|
|
|
195,724
|
|
|
|
|
|
|
| Compensation expense related to granting of stock awards |
|
1,949
|
|
|
$ 59
|
[2] |
|
|
1,890
|
|
|
| Purchase of vested employee restricted stock units (in shares) |
[2] |
|
|
|
(27,072)
|
|
|
|
|
|
|
| Purchase of vested employee restricted stock units |
|
(127)
|
|
|
$ (8)
|
[2] |
|
|
(119)
|
|
|
| Payment of dividends on common stock |
|
(60)
|
|
|
|
|
|
|
(60)
|
|
|
| Dividend equivalents, net of forfeitures |
|
22
|
|
|
|
|
|
|
|
22
|
|
| Net unrealized gain (loss) on derivatives |
|
(840)
|
|
|
|
|
|
|
|
|
(840)
|
| Ending balance (in shares) at Mar. 31, 2023 |
[2] |
|
|
|
4,873,980
|
|
134,839
|
|
|
|
|
| Ending balance at Mar. 31, 2023 |
|
485,662
|
|
|
$ 1,463
|
[2] |
$ 40
|
[2] |
1,678,554
|
(1,196,497)
|
2,102
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
|
4,705,328
|
134,839
|
4,705,328
|
[2] |
134,839
|
[2] |
|
|
|
| Beginning balance at Dec. 31, 2022 |
|
520,619
|
|
|
$ 1,412
|
[2] |
$ 40
|
[2] |
1,676,843
|
(1,160,618)
|
2,942
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ (161,705)
|
|
|
|
|
|
|
|
|
|
| Repurchase of common stock (in shares) |
|
0
|
|
|
|
|
|
|
|
|
|
| Net unrealized gain (loss) on derivatives |
|
$ (1,231)
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
|
4,865,759
|
134,839
|
4,865,759
|
[2] |
134,839
|
[2] |
|
|
|
| Ending balance at Jun. 30, 2023 |
|
360,574
|
|
|
$ 1,462
|
[2] |
$ 40
|
[2] |
1,679,622
|
(1,322,261)
|
1,711
|
| Beginning balance (in shares) at Mar. 31, 2023 |
[2] |
|
|
|
4,873,980
|
|
134,839
|
|
|
|
|
| Beginning balance at Mar. 31, 2023 |
|
485,662
|
|
|
$ 1,463
|
[2] |
$ 40
|
[2] |
1,678,554
|
(1,196,497)
|
2,102
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(125,802)
|
|
|
|
|
|
|
|
(125,802)
|
|
| Compensation expense related to granting of stock awards (in shares) |
[2] |
|
|
|
(7,449)
|
|
|
|
|
|
|
| Compensation expense related to granting of stock awards |
|
1,049
|
|
|
$ 0
|
[2] |
|
|
1,049
|
|
|
| Repurchase of common stock (in shares) |
[2] |
|
|
|
(215)
|
|
|
|
|
|
|
| Repurchase of common stock |
|
(1)
|
|
|
$ (1)
|
[2] |
|
|
|
|
|
| Purchase of vested employee restricted stock units (in shares) |
[2] |
|
|
|
(557)
|
|
|
|
|
|
|
| Purchase of vested employee restricted stock units |
|
(2)
|
|
|
$ 0
|
[2] |
|
|
(2)
|
|
|
| Payment of dividends on common stock |
|
21
|
|
|
|
|
|
|
21
|
|
|
| Dividend equivalents, net of forfeitures |
|
38
|
|
|
|
|
|
|
|
38
|
|
| Net unrealized gain (loss) on derivatives |
|
(391)
|
|
|
|
|
|
|
|
|
(391)
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
|
4,865,759
|
134,839
|
4,865,759
|
[2] |
134,839
|
[2] |
|
|
|
| Ending balance at Jun. 30, 2023 |
|
$ 360,574
|
|
|
$ 1,462
|
[2] |
$ 40
|
[2] |
$ 1,679,622
|
$ (1,322,261)
|
$ 1,711
|
|
|